Tumor Irradiation

New Agents Heighten Tumor Cell Death After Radiation Therapy

Published in Cancer Weekly, January 29th, 2002

by Sonia Nichols, senior medical writer - Two new agents being tested at Stanford University in California have been determined to increase the effectiveness of radiation therapy for inhibiting tumor growth.

Stanford University Medical Center investigator S. Ning and colleagues in the Department of Radiation Oncology recently concluded SU6668 and SU5416 are valuable adjuvants to irradiation therapy for increasing tumor cell death, based on their studies of irradiated mice implanted with SCC VII cells, which express several key angiogenic growth factors as well as their receptors.

The two molecular inhibitors, SU6668 and SU5416, hinder the activity of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-01-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry